$13M sweet spot round size
Most of their 19 investments are in rounds between $4.5M and $22M
2016
ONL Therapeutics raised $15M on March 8, 2023
Investors: Bios Partners, 凯泰资本, Michigan Capital Network and Visionary Venture Fund
RE-VANA raised $12M on November 30, 2022
Investors: InFocus Capital Partners, -, Fund NI, Techstart Ventures LLP and Visionary Venture Fund
Iantrek Inc raised $23M on August 30, 2022
Investors: Sectoral Asset Management and Visionary Venture Fund
Aurion Biotech raised $120M on April 12, 2022
Investors: -, Flying L Partners and Visionary Venture Fund
Undisclosed raised $45M on August 10, 2021
Investors: SC Master Fund, Bluestem Capital Co, Longitude Capital, Medicxi, RA Capital Management, L.P. and Visionary Venture Fund
ORASIS PHARMACEUTICALS raised $30M on September 10, 2020
Investors: Maverick Ventures, Bluestem Capital Co, LifeSci Venture Partners and Visionary Venture Fund
TearClear raised $22M on August 11, 2020
Investors: Bluestem Capital Co, Flying L Partners and Visionary Venture Fund
RE-VANA raised $3.3M on June 2, 2020
Investors: InFocus Capital Partners, Clarendon Fund Managers, -, Techstart Ventures LLP and Visionary Venture Fund
Tarsus Pharmaceuticals, Inc. raised $60M on January 8, 2020
Investors: Aperture Venture Partners, Frazier Healthcare Partners, Flying L Partners and Visionary Venture Fund
Surface Ophthalmics, Inc. raised $21M on July 11, 2018
Investors: Visionary Venture Fund